Austin, TX -- (SBWIRE) -- 05/01/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-
Nuance Communications Inc. (NASDAQ:NUAN) declined 17.34% to $19.24 on a traded volume of 10.21 million shares. The Company announced that its Board of Directors has approved a $500 million stock repurchase plan, reflecting the Company's strong balance sheet and prospects for continued growth. Under the plan, Nuance intends to repurchase up to $500 million of its outstanding shares of common stock.
Can NUAN Continue To Move Higher? Find Out Here
NeoStem Inc. (NYSEMKT: NBS) slipped 17.51% to $0.520 on a traded volume 4.31 million shares. NeoStem, Inc. and its subsidiary, Progenitor Cell Therapy LLC announced the execution of a Services Agreement with Sentien Biotechnologies, Inc. under which PCT will provide services to support Sentien's development of its cell therapy product, including technology transfer, staff training, and manufacturing. Sentien is developing an allogeneic cell therapy product consisting of bone marrow derived mesenchymal stem cells seeded onto a medical device for critical care indications.
Can NBS Extend Gain? Find Out Here
Delcath Systems, Inc. (NASDAQ:DCTH) moved down 17.27% to $1.15 on a traded volume of 2.74 million shares. The Company said it will eliminate jobs and move its headquarters to reduce its spending. Delcath said it will cut costs by eliminating 21 percent of its staff positions. It also plans to move its New York City operations to a less expensive satellite office in New Jersey. The address of its headquarters will change to its Queensbury, N.Y., facilities.
How Should Investors Trade DCTH Now? Find Out Here
Pitney Bowes Inc. (NYSE:PBI) declined 17.59% to $13.34 on a traded volume of 8.46 million shares. The Company reported first quarter profit of $67.5 million or 33 cents a share from $158.7 million or 79 cents a share in the prior year period. Revenue declined 4.4% to $1.17 billion. Analysts polled by Thomson Reuters most recently projected earnings of 44 cents on revenue of $1.2 billion.
How Should Investors Trade PBI Now? Find Out Here
Jackpotpennystocks.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Jackpotpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Jackpotpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)